Preferred Label : lusutrombopag;

UNII : 6LL5JFU42F;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.ema.europa.eu/en/medicines/human/EPAR/lusutrombopag-shionogi
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
lusutrombopag
lusutrombopag
adult
hemorrhage
thrombocytopenia
liver diseases
administration, oral
receptors, thrombopoietin
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
lusutrombopag
drug evaluation, preclinical
cinnamates
thiazoles
cinnamates
thiazoles

---
Nous contacter.
26/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.